Introduction Interstitial lung disease (ILD) is a heterogenous group of diffuse parenchymal lung diseases characterised by varying degrees of inflammation and fibrosis [1]. Differentiating between idiopathic pulmonary fibrosis (IPF) and non-IPF ILD is the first step in management, as this distinction impacts prognosis and treatment [2, 3]. Guidelines recommend the employment of a multidisciplinary team (MDT) discussion as the gold-standard approach to determining diagnosis and treatment [4].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile